This research seeks to discover and develop new asymmetric processes for use in the synthesis of enantiomerically pure organic substances. To the extent that this aim is realized, the syntheses of many fine chemical products, especially pharmaceuticals, will be simplified. About a year ago, under support by this grant, we discovered a general catalytic method for the asymmetric dihydroxylation (ADH) of olefins. At the heart of this proposal are the plans for developing this new asymmetric process. A major effort will be directed toward finding even better asymmetric ligands while at the same time trying to achieve the mechanistic insight which will make the ligand-design work more rational. The ADH process is also being extended to the area of catalytic oxyamination. The substrate scope of the process will be carefully examined. At present almost any olefin is a possible candidate since the asymmetric induction does not depend on prior binding of the substrate to the catalyst. Synthetic applications for the now readily available homochiral diols will receive emphasis. The main thrust relies on conversion of the diols into epoxide-like synthons, such as 1,2-cyclic sulfates. This work has a """"""""synthetic methods"""""""" orientation but also includes planned syntheses of various biologically active substances (e.g. beta-lactams, diltiazem, brassinolide, antibiotic AT-125, cianidanol, etc.). Homochiral diols of C2 symmetry are now easily prepared and will be examined as chiral auxillaries/ligands for other asymmetric processes. Encouraged by the successful asymmetric dihydroxylation of isolated olefins, a continuing long-range goal of this project is asymmetric epoxidation of isolated olefins.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Method to Extend Research in Time (MERIT) Award (R37)
Project #
Application #
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Scripps Research Institute
La Jolla
United States
Zip Code
Hein, Jason E; Tripp, Jonathan C; Krasnova, Larissa B et al. (2009) Copper(I)-catalyzed cycloaddition of organic azides and 1-iodoalkynes. Angew Chem Int Ed Engl 48:8018-21
Kwok, Sen Wai; Hein, Jason E; Fokin, Valery V et al. (2008) REGIOSELECTIVE SYNTHESIS OF EITHER 1H- OR 2H-1,2,3- TRIAZOLES VIA MICHAEL ADDITION TO alpha,ss-UNSATURATED KETONES. Heterocycles 76:1141-1154
Kalisiak, Jaroslaw; Sharpless, K Barry; Fokin, Valery V (2008) Efficient synthesis of 2-substituted-1,2,3-triazoles. Org Lett 10:3171-4
Whiting, Matthew; Fokin, Valery V (2006) Copper-catalyzed reaction cascade: direct conversion of alkynes into N-sulfonylazetidin-2-imines. Angew Chem Int Ed Engl 45:3157-61
Cassidy, Michael P; Raushel, Jessica; Fokin, Valery V (2006) Practical synthesis of amides from in situ generated copper(I) acetylides and sulfonyl azides. Angew Chem Int Ed Engl 45:3154-7
Johnson, Steven M; Petrassi, H Michael; Palaninathan, Satheesh K et al. (2005) Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation. J Med Chem 48:1576-87
Himo, Fahmi; Lovell, Timothy; Hilgraf, Robert et al. (2005) Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. J Am Chem Soc 127:210-6
Zhang, Li; Chen, Xinguo; Xue, Peng et al. (2005) Ruthenium-catalyzed cycloaddition of alkynes and organic azides. J Am Chem Soc 127:15998-9
Hansen, Trond V; Wu, Peng; Fokin, Valery V (2005) One-pot copper(I)-catalyzed synthesis of 3,5-disubstituted isoxazoles. J Org Chem 70:7761-4
Radic, Zoran; Manetsch, Roman; Krasinski, Antoni et al. (2005) Molecular basis of interactions of cholinesterases with tight binding inhibitors. Chem Biol Interact 157-158:133-41

Showing the most recent 10 out of 42 publications